• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜗牛通过转录抑制 4E-BP1 来决定对 mTOR 激酶抑制剂的治疗反应。

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.

机构信息

Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, 40506, USA.

Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, 40506, USA.

出版信息

Nat Commun. 2017 Dec 20;8(1):2207. doi: 10.1038/s41467-017-02243-3.

DOI:10.1038/s41467-017-02243-3
PMID:29263324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5738350/
Abstract

Loss of 4E-BP1 expression has been linked to cancer progression and resistance to mTOR inhibitors, but the mechanism underlying 4E-BP1 downregulation in tumors remains unclear. Here we identify Snail as a strong transcriptional repressor of 4E-BP1. We find that 4E-BP1 expression inversely correlates with Snail level in cancer cell lines and clinical specimens. Snail binds to three E-boxes present in the human 4E-BP1 promoter to repress transcription of 4E-BP1. Ectopic expression of Snail in cancer cell lines lacking Snail profoundly represses 4E-BP1 expression, promotes cap-dependent translation in polysomes, and reduces the anti-proliferative effect of mTOR kinase inhibitors. Conversely, genetic and pharmacological inhibition of Snail function restores 4E-BP1 expression and sensitizes cancer cells to mTOR kinase inhibitors by enhancing 4E-BP1-mediated translation-repressive effect on cell proliferation and tumor growth. Our study reveals a critical Snail-4E-BP1 signaling axis in tumorigenesis, and provides a rationale for targeting Snail to improve mTOR-targeted therapies.

摘要

4E-BP1 表达的缺失与癌症的进展和对 mTOR 抑制剂的耐药性有关,但肿瘤中 4E-BP1 下调的机制尚不清楚。在这里,我们鉴定出 Snail 是 4E-BP1 的一个强有力的转录抑制因子。我们发现,在癌细胞系和临床标本中,4E-BP1 的表达与 Snail 水平呈负相关。Snail 结合到人类 4E-BP1 启动子中的三个 E 盒上,抑制 4E-BP1 的转录。在缺乏 Snail 的癌细胞系中异位表达 Snail 会显著抑制 4E-BP1 的表达,促进多核糖体中帽依赖性翻译,并降低 mTOR 激酶抑制剂的抗增殖作用。相反,Snail 功能的遗传和药理学抑制通过增强 4E-BP1 对细胞增殖和肿瘤生长的翻译抑制作用来恢复 4E-BP1 的表达,并使癌细胞对 mTOR 激酶抑制剂敏感。我们的研究揭示了肿瘤发生中的一个关键的 Snail-4E-BP1 信号轴,并为靶向 Snail 以改善 mTOR 靶向治疗提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/c70758c577f2/41467_2017_2243_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/99ec81a07d33/41467_2017_2243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/e5f6ac555716/41467_2017_2243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/15cf8bc40e7a/41467_2017_2243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/b595564b3f8d/41467_2017_2243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/9a19ec803bb1/41467_2017_2243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/ea02864e34cd/41467_2017_2243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/1b39778dfb51/41467_2017_2243_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/c70758c577f2/41467_2017_2243_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/99ec81a07d33/41467_2017_2243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/e5f6ac555716/41467_2017_2243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/15cf8bc40e7a/41467_2017_2243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/b595564b3f8d/41467_2017_2243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/9a19ec803bb1/41467_2017_2243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/ea02864e34cd/41467_2017_2243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/1b39778dfb51/41467_2017_2243_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b1/5738350/c70758c577f2/41467_2017_2243_Fig8_HTML.jpg

相似文献

1
Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.蜗牛通过转录抑制 4E-BP1 来决定对 mTOR 激酶抑制剂的治疗反应。
Nat Commun. 2017 Dec 20;8(1):2207. doi: 10.1038/s41467-017-02243-3.
2
AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.AKT抑制通过增强PRAS40对mTORC1/4E-BP1轴的抑制功能来克服雷帕霉素耐药性。
Oncotarget. 2015 Jun 10;6(16):13962-77. doi: 10.18632/oncotarget.3920.
3
Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail.4E-BP1功能丧失通过帽依赖性的Snail翻译激活诱导上皮-间质转化并促进癌细胞迁移和侵袭。
Oncotarget. 2014 Aug 15;5(15):6015-27. doi: 10.18632/oncotarget.2109.
4
4E-BP1, a multifactor regulated multifunctional protein.4E-BP1,一种受多因素调控的多功能蛋白质。
Cell Cycle. 2016;15(6):781-6. doi: 10.1080/15384101.2016.1151581.
5
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.eIF4E/4E-BP 比值可预测 mTOR 靶向治疗的疗效。
Cancer Res. 2012 Dec 15;72(24):6468-76. doi: 10.1158/0008-5472.CAN-12-2395. Epub 2012 Oct 24.
6
Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.淫羊藿苷II,一种天然的mTOR抑制剂,通过抑制肉瘤细胞中的mTORC1-4E-BP1轴来破坏异常的能量稳态。
Oncotarget. 2016 May 10;7(19):27819-37. doi: 10.18632/oncotarget.8538.
7
Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.新衍生的犬血管肉瘤细胞系中 mTORC2/Akt/4E-BP1 通路的组成性磷酸化。
BMC Vet Res. 2012 Jul 29;8:128. doi: 10.1186/1746-6148-8-128.
8
Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.对4E-BP1作为mTOR底物研究的重新评估——一种规范性批判。
Eur J Cell Biol. 2017 Jun;96(4):325-336. doi: 10.1016/j.ejcb.2017.03.013. Epub 2017 Apr 8.
9
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.mTOR 靶向 4E-BP1/2 抑制 PTEN 驱动的前列腺癌的肿瘤生长并促进其缺氧耐受。
Mol Cancer Res. 2018 Apr;16(4):682-695. doi: 10.1158/1541-7786.MCR-17-0696. Epub 2018 Feb 16.
10
Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.在非小细胞肺癌中,Twist1通过mTOR介导对4E-BP1的调控。
Oncotarget. 2015 Oct 20;6(32):33006-18. doi: 10.18632/oncotarget.5026.

引用本文的文献

1
Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells.B56-PP2A的小分子调节剂可恢复4E-BP功能,以抑制癌细胞中eIF4E依赖性翻译。
J Clin Invest. 2025 Jan 27;135(4):e176093. doi: 10.1172/JCI176093.
2
Effect of Electric Fields on the Mechanical Mechanism of Regorafenib-VEGFR2 Interaction to Enhance Inhibition of Hepatocellular Carcinoma.电场对regorafenib与血管内皮生长因子受体2(VEGFR2)相互作用的力学机制以增强对肝细胞癌抑制作用的影响
Biomolecules. 2025 Jan 1;15(1):42. doi: 10.3390/biom15010042.
3
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.

本文引用的文献

1
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation.联合 mTOR/HDAC 抑制的协同靶标促进 MYC 降解。
Mol Cancer Ther. 2017 Sep;16(9):2008-2021. doi: 10.1158/1535-7163.MCT-17-0171. Epub 2017 May 18.
2
Snail controls proliferation of Drosophila ovarian epithelial follicle stem cells, independently of E-cadherin.蜗牛蛋白独立于E-钙黏蛋白调控果蝇卵巢上皮卵泡干细胞的增殖。
Dev Biol. 2016 Jun 15;414(2):142-8. doi: 10.1016/j.ydbio.2016.04.022. Epub 2016 Apr 30.
3
4E-BP restrains eIF4E phosphorylation.4E-BP抑制真核翻译起始因子4E(eIF4E)的磷酸化。
HMGA1 通过 ETS1-FKBP12 轴使食管鳞癌细胞对 mTOR 抑制剂敏感。
Int J Biol Sci. 2024 Apr 22;20(7):2640-2657. doi: 10.7150/ijbs.95595. eCollection 2024.
4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
5
Cancer cell plasticity during tumor progression, metastasis and response to therapy.肿瘤进展、转移及对治疗的反应过程中的癌细胞可塑性。
Nat Cancer. 2023 Aug;4(8):1063-1082. doi: 10.1038/s43018-023-00595-y. Epub 2023 Aug 3.
6
Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors.增强 PD-L1 翻译旁路会降低对 mTOR 激酶抑制剂的治疗反应。
Cell Rep. 2023 Jul 25;42(7):112764. doi: 10.1016/j.celrep.2023.112764. Epub 2023 Jul 4.
7
The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches.癌症中的mTOR信号通路与mTOR抑制剂:新一代抑制剂与方法
Curr Mol Med. 2024;24(4):478-494. doi: 10.2174/1566524023666230509161645.
8
Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer.PD-1/PD-L1与PI3K/AKT/mTOR通路相互作用在非小细胞肺癌进展和治疗中的临床意义
J Cancer. 2022 Oct 3;13(13):3434-3443. doi: 10.7150/jca.77619. eCollection 2022.
9
METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.METTL3-IGF2BP3轴通过调节精胺合酶的m6A修饰介导胰腺癌的增殖和迁移。
Front Oncol. 2022 Oct 6;12:962204. doi: 10.3389/fonc.2022.962204. eCollection 2022.
10
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?上皮-间充质可塑性的转录后和转录调控:为何有如此多的调控因子?
Cell Mol Life Sci. 2022 Mar 12;79(3):182. doi: 10.1007/s00018-022-04199-0.
Translation (Austin). 2013 Jul 24;1(2):e25819. doi: 10.4161/trla.25819. eCollection 2013.
4
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.上皮-间质转化对胰腺癌转移并非必需,但可诱导其产生化疗耐药性。
Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.
5
The role of Snail1 transcription factor in colorectal cancer progression and metastasis.Snail1转录因子在结直肠癌进展和转移中的作用。
Contemp Oncol (Pozn). 2015;19(4):265-70. doi: 10.5114/wo.2014.42173. Epub 2015 Sep 28.
6
AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.AKT抑制通过增强PRAS40对mTORC1/4E-BP1轴的抑制功能来克服雷帕霉素耐药性。
Oncotarget. 2015 Jun 10;6(16):13962-77. doi: 10.18632/oncotarget.3920.
7
An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors.一种进化上保守的DNA结构决定了TWIST家族bHLH转录因子的靶标特异性。
Genes Dev. 2015 Mar 15;29(6):603-16. doi: 10.1101/gad.242842.114. Epub 2015 Mar 11.
8
Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.靶向 eIF4F 翻译起始复合物:癌症发展的关键枢纽。
Cancer Res. 2015 Jan 15;75(2):250-63. doi: 10.1158/0008-5472.CAN-14-2789.
9
mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.雷帕霉素靶蛋白(mTOR)激酶抑制剂与组蛋白去乙酰化酶抑制剂协同作用以杀死B细胞急性淋巴细胞白血病细胞。
Oncotarget. 2015 Feb 10;6(4):2088-100. doi: 10.18632/oncotarget.2992.
10
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.组蛋白去乙酰化酶及其抑制剂在癌症、神经疾病和免疫紊乱中的作用。
Nat Rev Drug Discov. 2014 Sep;13(9):673-91. doi: 10.1038/nrd4360. Epub 2014 Aug 18.